Xenon Inhalation During Orthopaedic Surgery in Elderly Subjects.

NCT00192959 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2005-09-19

No results posted yet for this study

Summary

The primary objective was to explore the feasibility of inhaled xenon for sedation in terms of its effect on postoperative cognitive function in elderly, in comparison with the postoperative cognitive function found after IV propofol sedation in the same population.The secondary objectives were designed to assess the feasibility of xenon sedation in terms of its effects on different neuropsycho-logical test variables, vital signs, sedation levels and safety in elderly orthopaedic subjects.

Conditions

  • Anaesthesia
  • Postoperative Cognitive Function

Interventions

DRUG

Xenon vs propofol

Sponsors & Collaborators

  • Linde AG

    collaborator INDUSTRY
  • Rigshospitalet, Denmark

    lead OTHER

Principal Investigators

  • Lars S Rasmussen, MD PhD · Rigshospitalet, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-03-31
Completion
2004-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00192959 on ClinicalTrials.gov